This website uses cookies to improve the site and user experience. By continuing to browse this site,
you agree to accept our use of cookies. For more information, please review our Cookies Policy
ESMO-BC 2020
Presentations
Tucatinib | Breast Cancer | Abstract 1005
Tucatinib vs placebo added to trastuzumab and capecitabine for patients with previously treated HER2+ metastatic breast cancer with brain metastases (HER2CLIMB)
HEOR | Breast Cancer | Abstract 169P
Trastuzumab use among patients with HER2-positive metastatic breast cancer in an electronic health records database
HEOR | Breast Cancer | Abstract 174P
Occurrence of brain metastasis and treatment patterns among patients with HER2-positive metastatic breast cancer